Form 4: Hims & Hers CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Hims & Hers Health, Inc. CFO Oluyemi Okupe sold 23,584 shares of Class A Common Stock for an average price of $57.7411 under a pre-arranged trading plan.
Summary
- Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported a transaction on September 22, 2025.
- The transaction involved the sale of 23,584 shares of Class A Common Stock.
- The shares were sold at an average weighted price of $57.7411, with individual sales ranging from $57.38 to $58.245.
- This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Okupe on May 21, 2025.
- Following this transaction, Mr. Okupe directly beneficially owns 105,400 shares of Class A Common Stock.
- Additionally, Mr. Okupe indirectly beneficially owns 7,853 shares held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
Sentiment
Score: 5
Explanation: The CFO's sale of shares, while executed under a pre-arranged 10b5-1 plan, represents a reduction in insider holdings. The pre-planned nature mitigates immediate negative sentiment, but it is still a sale by a key executive, leading to a neutral to slightly negative interpretation.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was scheduled in advance and not based on immediate, non-public information.
Negatives
- A key executive, the Chief Financial Officer, reduced their direct ownership in the company by selling 23,584 shares.
- Insider selling, even if planned, can sometimes be perceived negatively by the market as a reduction in management's direct stake.
Risks
- No specific risks beyond the general implication of insider selling are mentioned in this Form 4.
Future Outlook
No forward-looking statements or guidance are provided in this insider transaction report.
Management Comments
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
Industry Context
This Form 4 reports an individual insider transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reporting person adopted a Rule 10b5-1 trading plan on May 21, 2025, which governed the reported sale. | 05/21/2025 | A 10b5-1 plan allows insiders to sell shares at pre-determined times or prices, providing an affirmative defense against insider trading allegations and promoting orderly sales. |
Related Party Transactions
- Indirect beneficial ownership of 7,853 shares is held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
Stakeholder Impact
- Shareholders may view the reduction in direct insider ownership by a key executive as a potential signal, although the pre-planned nature of the sale under a 10b5-1 plan typically lessens negative interpretations.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date the Rule 10b5-1 trading plan was adopted by Oluyemi Okupe. |
| 09/22/2025 | Date of the reported transaction (sale of Class A Common Stock). |
| 09/24/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdThe sale by the Chief Financial Officer, while executed under a pre-arranged 10b5-1 trading plan, represents a reduction in insider ownership. This transaction alone does not indicate a fundamental shift in the company's prospects but warrants monitoring for further insider activity or changes in company fundamentals. Investors should hold and observe.
Keywords
Hims & Hers, HIMS, Oluyemi Okupe, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.